Trinity Biotech ADR buy StockNews.com
Start price
26.02.23
/
50%
€0.99
Target price
26.02.24
-
Performance (%)
-56.95%
End price
27.02.24
-
Summary
This prediction is currently being closed. Massive losses of -56.95% have been the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Trinity Biotech ADR where he still thinks Trinity Biotech ADR is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Trinity Biotech ADR | - | - | - |
iShares Core DAX® | -0.552% | 3.281% | 15.052% |
iShares Nasdaq 100 | -1.415% | 4.535% | 26.243% |
iShares Nikkei 225® | -0.877% | -1.739% | 4.897% |
iShares S&P 500 | -0.415% | 3.239% | 23.253% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten